(Total Views: 328)
Posted On: 04/11/2022 3:40:50 PM
Post# of 98
$ATNM News Article - Actinium Pharmaceuticals Presents Preclinical Data at AACR Showing HER3 Targeted Radiotherapy Combined with the CD47 Immunotherapy Magrolimab Increases the Anti-tumor Effect https://marketwirenews.com/news-releases/acti...98933.html
(0)
(0)
My Twitter: WhyteStocks
Scroll down for more posts ▼
